Details for New Drug Application (NDA): 084362
✉ Email this page to a colleague
NDA 084362 describes GLUTETHIMIDE, which is a drug marketed by Halsey, Lannett, Ucb Inc, Upsher Smith Labs, Vitarine, and Watson Labs, and is included in nine NDAs. Additional details are available on the GLUTETHIMIDE profile page.
The generic ingredient in GLUTETHIMIDE is glutethimide. There are four drug master file entries for this compound. Additional details are available on the glutethimide profile page.
The generic ingredient in GLUTETHIMIDE is glutethimide. There are four drug master file entries for this compound. Additional details are available on the glutethimide profile page.
Summary for 084362
| Tradename: | GLUTETHIMIDE |
| Applicant: | Watson Labs |
| Ingredient: | glutethimide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084362
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
